Logo image of COV.PA

COVIVIO (COV.PA) Stock Fundamental Analysis

Europe - EPA:COV - FR0000064578 - REIT

57.75 EUR
-0.45 (-0.77%)
Last: 10/17/2025, 7:00:00 PM
Fundamental Rating

3

COV gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 39 industry peers in the Diversified REITs industry. There are concerns on the financial health of COV while its profitability can be described as average. COV is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year COV was profitable.
In the past year COV had a positive cash flow from operations.
COV had positive earnings in 4 of the past 5 years.
In the past 5 years COV always reported a positive cash flow from operatings.
COV.PA Yearly Net Income VS EBIT VS OCF VS FCFCOV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

1.2 Ratios

COV has a Return On Assets (1.63%) which is in line with its industry peers.
With a Return On Equity value of 5.08%, COV perfoms like the industry average, outperforming 51.28% of the companies in the same industry.
COV has a Return On Invested Capital (3.21%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for COV is in line with the industry average of 3.49%.
The last Return On Invested Capital (3.21%) for COV is above the 3 year average (2.97%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.63%
ROE 5.08%
ROIC 3.21%
ROA(3y)-1.05%
ROA(5y)0.29%
ROE(3y)-3.48%
ROE(5y)0.76%
ROIC(3y)2.97%
ROIC(5y)2.68%
COV.PA Yearly ROA, ROE, ROICCOV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

COV has a Profit Margin (30.46%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of COV has declined.
COV has a worse Operating Margin (57.81%) than 66.67% of its industry peers.
In the last couple of years the Operating Margin of COV has remained more or less at the same level.
With a Gross Margin value of 74.42%, COV perfoms like the industry average, outperforming 53.85% of the companies in the same industry.
COV's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 57.81%
PM (TTM) 30.46%
GM 74.42%
OM growth 3Y-1.46%
OM growth 5Y-1.11%
PM growth 3Y-61.53%
PM growth 5Y-38.78%
GM growth 3Y-2.18%
GM growth 5Y-0.89%
COV.PA Yearly Profit, Operating, Gross MarginsCOV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so COV is destroying value.
COV has more shares outstanding than it did 1 year ago.
The number of shares outstanding for COV has been increased compared to 5 years ago.
COV has a better debt/assets ratio than last year.
COV.PA Yearly Shares OutstandingCOV.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
COV.PA Yearly Total Debt VS Total AssetsCOV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

COV has an Altman-Z score of 0.54. This is a bad value and indicates that COV is not financially healthy and even has some risk of bankruptcy.
COV has a worse Altman-Z score (0.54) than 71.79% of its industry peers.
COV has a debt to FCF ratio of 28.44. This is a negative value and a sign of low solvency as COV would need 28.44 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 28.44, COV is doing worse than 74.36% of the companies in the same industry.
COV has a Debt/Equity ratio of 1.07. This is a high value indicating a heavy dependency on external financing.
COV's Debt to Equity ratio of 1.07 is on the low side compared to the rest of the industry. COV is outperformed by 82.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 28.44
Altman-Z 0.54
ROIC/WACC0.55
WACC5.81%
COV.PA Yearly LT Debt VS Equity VS FCFCOV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 0.76 indicates that COV may have some problems paying its short term obligations.
With a decent Current ratio value of 0.76, COV is doing good in the industry, outperforming 66.67% of the companies in the same industry.
COV has a Quick Ratio of 0.76. This is a bad value and indicates that COV is not financially healthy enough and could expect problems in meeting its short term obligations.
With a decent Quick ratio value of 0.69, COV is doing good in the industry, outperforming 64.10% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.69
COV.PA Yearly Current Assets VS Current LiabilitesCOV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

5

3. Growth

3.1 Past

COV shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.98%.
COV shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -3.39% yearly.
Looking at the last year, COV shows a very strong growth in Revenue. The Revenue has grown by 27.96%.
The Revenue has been growing slightly by 1.17% on average over the past years.
EPS 1Y (TTM)5.98%
EPS 3Y0.91%
EPS 5Y-3.39%
EPS Q2Q%6.25%
Revenue 1Y (TTM)27.96%
Revenue growth 3Y9.01%
Revenue growth 5Y1.17%
Sales Q2Q%-30.61%

3.2 Future

Based on estimates for the next years, COV will show a small growth in Earnings Per Share. The EPS will grow by 3.36% on average per year.
The Revenue is expected to grow by 4.04% on average over the next years.
EPS Next Y5.08%
EPS Next 2Y3.26%
EPS Next 3Y3.36%
EPS Next 5YN/A
Revenue Next Year1.82%
Revenue Next 2Y3.23%
Revenue Next 3Y4.04%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
COV.PA Yearly Revenue VS EstimatesCOV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
COV.PA Yearly EPS VS EstimatesCOV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 12.53 indicates a correct valuation of COV.
Compared to the rest of the industry, the Price/Earnings ratio of COV indicates a somewhat cheap valuation: COV is cheaper than 61.54% of the companies listed in the same industry.
COV is valuated cheaply when we compare the Price/Earnings ratio to 27.40, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 12.12 indicates a correct valuation of COV.
Based on the Price/Forward Earnings ratio, COV is valued a bit more expensive than the industry average as 64.10% of the companies are valued more cheaply.
The average S&P500 Price/Forward Earnings ratio is at 22.94. COV is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 12.53
Fwd PE 12.12
COV.PA Price Earnings VS Forward Price EarningsCOV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

COV's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, COV is valued a bit more expensive than the industry average as 61.54% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 16.39
EV/EBITDA 17.25
COV.PA Per share dataCOV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates COV does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)2.46
PEG (5Y)N/A
EPS Next 2Y3.26%
EPS Next 3Y3.36%

4

5. Dividend

5.1 Amount

COV has a Yearly Dividend Yield of 6.01%, which is a nice return.
COV's Dividend Yield is a higher than the industry average which is at 5.75.
Compared to an average S&P500 Dividend Yield of 2.36, COV pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.01%

5.2 History

The dividend of COV decreases each year by -1.54%.
Dividend Growth(5Y)-1.54%
Div Incr Years2
Div Non Decr Years2
COV.PA Yearly Dividends per shareCOV.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

COV pays out 92.95% of its income as dividend. This is not a sustainable payout ratio.
DP92.95%
EPS Next 2Y3.26%
EPS Next 3Y3.36%
COV.PA Yearly Income VS Free CF VS DividendCOV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B
COV.PA Dividend Payout.COV.PA Dividend Payout, showing the Payout Ratio.COV.PA Dividend Payout.PayoutRetained Earnings

COVIVIO

EPA:COV (10/17/2025, 7:00:00 PM)

57.75

-0.45 (-0.77%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)07-21 2025-07-21/bmo
Earnings (Next)02-17 2026-02-17/amc
Inst Owners41.52%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap6.45B
Analysts81.25
Price Target64.25 (11.26%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.01%
Yearly Dividend0.72
Dividend Growth(5Y)-1.54%
DP92.95%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)5.79%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-4.52%
EPS NY rev (3m)-2.25%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)2.73%
Revenue NY rev (3m)2.25%
Valuation
Industry RankSector Rank
PE 12.53
Fwd PE 12.12
P/S 4.7
P/FCF 16.39
P/OCF 6.42
P/B 0.78
P/tB 0.82
EV/EBITDA 17.25
EPS(TTM)4.61
EY7.98%
EPS(NY)4.77
Fwd EY8.25%
FCF(TTM)3.52
FCFY6.1%
OCF(TTM)8.99
OCFY15.57%
SpS12.29
BVpS73.66
TBVpS70.57
PEG (NY)2.46
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.63%
ROE 5.08%
ROCE 3.59%
ROIC 3.21%
ROICexc 3.42%
ROICexgc 3.48%
OM 57.81%
PM (TTM) 30.46%
GM 74.42%
FCFM 28.68%
ROA(3y)-1.05%
ROA(5y)0.29%
ROE(3y)-3.48%
ROE(5y)0.76%
ROIC(3y)2.97%
ROIC(5y)2.68%
ROICexc(3y)3.08%
ROICexc(5y)2.79%
ROICexgc(3y)3.11%
ROICexgc(5y)2.81%
ROCE(3y)3.32%
ROCE(5y)3%
ROICexcg growth 3Y12.16%
ROICexcg growth 5Y0.31%
ROICexc growth 3Y11.77%
ROICexc growth 5Y0.14%
OM growth 3Y-1.46%
OM growth 5Y-1.11%
PM growth 3Y-61.53%
PM growth 5Y-38.78%
GM growth 3Y-2.18%
GM growth 5Y-0.89%
F-Score7
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 28.44
Debt/EBITDA 9.39
Cap/Depr 417.19%
Cap/Sales 44.51%
Interest Coverage 250
Cash Conversion 106.87%
Profit Quality 94.14%
Current Ratio 0.76
Quick Ratio 0.69
Altman-Z 0.54
F-Score7
WACC5.81%
ROIC/WACC0.55
Cap/Depr(3y)709.28%
Cap/Depr(5y)708.5%
Cap/Sales(3y)50.08%
Cap/Sales(5y)56.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.98%
EPS 3Y0.91%
EPS 5Y-3.39%
EPS Q2Q%6.25%
EPS Next Y5.08%
EPS Next 2Y3.26%
EPS Next 3Y3.36%
EPS Next 5YN/A
Revenue 1Y (TTM)27.96%
Revenue growth 3Y9.01%
Revenue growth 5Y1.17%
Sales Q2Q%-30.61%
Revenue Next Year1.82%
Revenue Next 2Y3.23%
Revenue Next 3Y4.04%
Revenue Next 5YN/A
EBIT growth 1Y-0.73%
EBIT growth 3Y7.42%
EBIT growth 5Y0.05%
EBIT Next Year12.82%
EBIT Next 3Y8.12%
EBIT Next 5Y7.56%
FCF growth 1Y42.08%
FCF growth 3YN/A
FCF growth 5Y31.13%
OCF growth 1Y30.56%
OCF growth 3Y12.5%
OCF growth 5Y4.86%